ID
17396
Description
Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00786331
Link
https://clinicaltrials.gov/show/NCT00786331
Keywords
Versions (1)
- 9/11/16 9/11/16 -
Uploaded on
September 11, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331
Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pemetrexed
Data type
boolean
Alias
- UMLS CUI [1]
- C0210657
Description
pregnant or lactating
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0032961
- UMLS CUI [1,2]
- C0006147
Description
medical condition
Data type
boolean
Alias
- UMLS CUI [1]
- C0012634
Description
brain metastases
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
concomitant treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C1707479
Similar models
Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331
- StudyEvent: Eligibility
C0232741 (UMLS CUI [2])
C0006147 (UMLS CUI [1,2])